MicroRNA-432 targeting E2F3 and P55PIK inhibits myogenesis through PI3K/AKT/mTOR signaling pathway

References

• Massie B, Conway M, Yonge R, Frostick S, Ledingham J, Sleight P, Radda G, Rajagopalan B. Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow. Circulation 1987; 76:1009-19; PMID:3664989; https://doi.org/10.1161/01.CIR.76.5.1009
   PubMed Web of Science ®Google Scholar
• Zurlo F, Larson K, Bogardus C, Ravussin E. Skeletal muscle metabolism is a major determinant of resting energy expenditure. J Clin Invest 1990; 86:1423-27; PMID:2243122; http://dx.doi.org/10.1172/JCI114857
   PubMed Web of Science ®Google Scholar
• Saltin B, Gollnick PD. Skeletal Muscle Adaptability: Significance for Metabolism and Performance. Comprehensive Physiology 2011; 555-631.
   Google Scholar
• Buckingham M, Bajard L, Chang T, Daubas P, Hadchouel J, Meilhac S, Montarras D, Rocancourt D, Relaix F. The formation of skeletal muscle: from somite to limb. J Anat 2003; 202:59-68; PMID:12587921
   PubMed Web of Science ®Google Scholar
• Buckingham M. Skeletal muscle formation in vertebrates. Curr Opin Genet Dev 2001; 11:440-48; PMID:11448631
   PubMed Web of Science ®Google Scholar
• Rudnicki MA, Schnegelsberg PN, Stead RH, Braun T, Arnold HH, Jaenisch R. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 1993; 75:1351-59; PMID:8269513
   PubMed Web of Science ®Google Scholar
• Yun K, Wold B. Skeletal muscle determination and differentiation: story of a core regulatory network and its context. Curr Opin Cell Biol 1996; 8:877-89; PMID:8939680; http://dx.doi.org/10.1016/S0955-0674(96)80091-3
   PubMed Web of Science ®Google Scholar
• Russell AP, Foletta VC, Snow RJ, Wadley GD. Skeletal muscle mitochondria: a major player in exercise, health and disease. Biochim Biophys Acta 2014; 1840:1276-84; PMID:24291686; http://dx.doi.org/10.1016/j.bbagen.2013.11.016
   PubMed Web of Science ®Google Scholar
• Tabebordbar M, Wang ET, Wagers AJ. Skeletal muscle degenerative diseases and strategies for therapeutic muscle repair. Annu Rev Pathol 2013; 8:441-75; PMID:23121053; http://dx.doi.org/10.1146/annurev-pathol-011811-132450
   PubMed Web of Science ®Google Scholar
• Ambros V. The functions of animal microRNAs. Nature 2004; 431:350-55; PMID:15372042; http://dx.doi.org/10.1038/nature02871
   PubMed Web of Science ®Google Scholar
• O'Rourke JR, Georges SA, Seay HR, Tapscott SJ, McManus MT, Goldhamer DJ, Swanson MS, Harfe BD. Essential role for Dicer during skeletal muscle development. Dev Biol 2007; 311:359-68; PMID:17936265; http://dx.doi.org/10.1016/j.ydbio.2007.08.032
   PubMed Web of Science ®Google Scholar
• Feng Y, Niu LL, Wei W, Zhang WY, Li XY, Cao JH, Zhao SH. A feedback circuit between miR-133 and the ERK1/2 pathway involving an exquisite mechanism for regulating myoblast proliferation and differentiation. Cell Death Dis 2013; 4:e934; PMID:24287695; http://dx.doi.org/10.1038/cddis.2013.462
   PubMed Web of Science ®Google Scholar
• Zhang D, Li X, Chen C, Li Y, Zhao L, Jing Y, Liu W, Wang X, Zhang Y, Xia H, Chang Y, Gao X, Yan J et al. Ying H. Attenuation of p38-mediated miR-1/133 expression facilitates myoblast proliferation during the early stage of muscle regeneration. PLoS One 2012; 7:e41478; PMID:22911796; http://dx.doi.org/10.1371/journal.pone.0041478
   PubMed Web of Science ®Google Scholar
• Dey BK, Gagan J, Dutta A. miR-206 and −486 induce myoblast differentiation by downregulating Pax7. Mol Cell Biol 2011; 31:203-14; PMID:21041476; http://dx.doi.org/10.1128/MCB.01009-10
   PubMed Web of Science ®Google Scholar
• Goljanek-Whysall K, Pais H, Rathjen T, Sweetman D, Dalmay T, Munsterberg A. Regulation of multiple target genes by miR-1 and miR-206 is pivotal for C2C12 myoblast differentiation. J Cell Sci 2012; 125:3590-600; PMID:22595520; http://dx.doi.org/10.1242/jcs.101758
   PubMed Web of Science ®Google Scholar
• Mi L, Li Y, Zhang Q, Zhao C, Peng Y, Yang G, Zheng X. MicroRNA-139-5p regulates C2C12 cell myogenesis through blocking Wnt/beta-catenin signaling pathway. Biochem Cell Biol 2015; 93:8-15; PMID:25529604; http://dx.doi.org/10.1139/bcb-2014-0079
   PubMed Web of Science ®Google Scholar
• Wei W, He HB, Zhang WY, Zhang HX, Bai JB, Liu HZ, Cao JH, Chang KC, Li XY, Zhao SH. miR-29 targets Akt3 to reduce proliferation and facilitate differentiation of myoblasts in skeletal muscle development. Cell Death Dis 2013; 4:e668; PMID:23764849; http://dx.doi.org/10.1038/cddis.2013.184.
   Google Scholar
• Liu T, Zhong S, Rao F, Xue Y, Qi Z, Wu S. Catheter ablation restores decreased plasma miR-409-3p and miR-432 in atrial fibrillation patients. Europace 2016; 18:92-99; PMID:25782451; http://dx.doi.org/10.1093/europace/euu366
   PubMed Web of Science ®Google Scholar
• Jiang N, Chen WJ, Zhang JW, Xu C, Zeng XC, Zhang T, Li Y, Wang GY. Downregulation of miR-432 activates Wnt/beta-catenin signaling and promotes human hepatocellular carcinoma proliferation. Oncotarget 2015; 6:7866-79; PMID:25797263; http://dx.doi.org/10.18632/oncotarget.3492
   PubMed Web of Science ®Google Scholar
• Das S, Bhattacharyya NP. Heat shock factor 1 regulates hsa-miR-432 expression in human cervical cancer cell line. Biochem Biophys Res Commun 2014; 453:461-66; PMID:25280995; http://dx.doi.org/10.1016/j.bbrc.2014.09.100
   PubMed Web of Science ®Google Scholar
• Rady B, Chen Y, Vaca P, Wang Q, Wang Y, Salmon P, Oberholzer J. Overexpression of E2F3 promotes proliferation of functional human beta cells without induction of apoptosis. Cell Cycle 2013; 12:2691-702; PMID:23907129; http://dx.doi.org/10.4161/cc.25834
   PubMed Web of Science ®Google Scholar
• Asp P, Acosta-Alvear D, Tsikitis M, van Oevelen C, Dynlacht BD. E2f3b plays an essential role in myogenic differentiation through isoform-specific gene regulation. Gen Dev 2009; 23:37-53; PMID:19136625; http://dx.doi.org/10.1101/gad.1727309
   PubMed Web of Science ®Google Scholar
• Kaliman P, Vinals F, Testar X, Palacin M, Zorzano A. Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells. J Biol Chem 1996; 271:19146-51; PMID:8702591; http://dx.doi.org/10.1074/jbc.271.32.19146
   PubMed Web of Science ®Google Scholar
• Leevers SJ, Vanhaesebroeck B, Waterfield MD. Signalling through phosphoinositide 3-kinases: the lipids take centre stage. Curr Opin Cell Biol 1999; 11:219-25; PMID:10209156; http://dx.doi.org/10.1016/S0955-0674(99)80029-5
   PubMed Web of Science ®Google Scholar
• Wang G, Cao X, Lai S, Luo X, Feng Y, Xia X, Yen PM, Gong J, Hu J. PI3K stimulates DNA synthesis and cell-cycle progression via its p55PIK regulatory subunit interaction with PCNA. Mol Cancer Ther 2013; 12:2100-09; PMID:23939377; http://dx.doi.org/10.1158/1535-7163.MCT-12-0920
   PubMed Web of Science ®Google Scholar
• Pons S, Asano T, Glasheen E, Miralpeix M, Zhang Y, Fisher TL, Myers MG, Sun XJ, White MF. The structure and function of p55PIK reveal a new regulatory subunit for phosphatidylinositol 3-kinase. Mol Cell Biol 1995; 15:4453-65; PMID:7542745
   PubMed Web of Science ®Google Scholar
• Hu J, Xia X, Cheng A, Wang G, Luo X, Reed MF, Fojo T, Oetting A, Gong J, Yen PM. A peptide inhibitor derived from p55PIK phosphatidylinositol 3-kinase regulatory subunit: a novel cancer therapy. Mol Cancer Ther 2008; 7:3719-28; PMID:19074847; http://dx.doi.org/10.1158/1535-7163. MCT-08-0499
   PubMed Web of Science ®Google Scholar
• Wang G, Deng Y, Cao X, Lai S, Tong Y, Luo X, Feng Y, Xia X, Gong J, Hu J. Blocking p55PIK signaling inhibits proliferation and induces differentiation of leukemia cells. Cell Death Differ 2012; 19:1870-79; PMID:22722333; http://dx.doi.org/10.1038/cdd.2012.70
   PubMed Web of Science ®Google Scholar
• Sun XJ, Zhao M, Yuan XH, Yu Q, Zheng LM, Fang MJ, Huang CZ. [Inhibitory effect of N-terminal of p55PIK–regulatory subunit of phosphoinositide-3 kinase–on proliferation of gastric cancer cell line MGC803 and its mechanism]. Ai Zheng 2006; 25:264-68; PMID:16536976
   PubMedGoogle Scholar
• Zhou Y, Li F, Tian X, Wang B, Ding M, Pang H. Changes in phosphatidylinositol 3-kinase 55 kDa gamma expression and subcellular localization may be caspase 6 dependent in paraquat-induced SH-SY5Y apoptosis. Hum Exp Toxicol 2014; 33:761-71; PMID:24130211; http://dx.doi.org/10.1177/0960327113499044
   PubMed Web of Science ®Google Scholar
• Leger B, Cartoni R, Praz M, Lamon S, Deriaz O, Crettenand A, Gobelet C, Rohmer P, Konzelmann M, Luthi F et al. Russell AP. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy. J Physiol 2006; 576:923-33; PMID:16916907; http://dx.doi.org/10.1113/jphysiol.2006.116715
   PubMed Web of Science ®Google Scholar
• Pallafacchina G, Calabria E, Serrano AL, Kalhovde JM, Schiaffino S. A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc Natl Acad Sci USA 2002; 99:9213-18; PMID:12084817; http://dx.doi.org/10.1073/pnas.142166599
   PubMed Web of Science ®Google Scholar
• Bolster DR, Crozier SJ, Kimball SR, Jefferson LS. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through downregulating mammalian target of rapamycin (mTOR) signaling. J Biol Chem 2002; 277:23977-80; PMID:11997383; http://dx.doi.org/10.1074/jbc.C200171200
   PubMed Web of Science ®Google Scholar
• Vogt PK. PI3-kinase, mTOR, protein synthesis and cancer. Trends Mol Med 2001; 7:482-84; PMID:11689313; http://dx.doi.org/10.1016/S1471-4914(01)02161-X
   PubMed Web of Science ®Google Scholar
• Altarejos JY, Montminy M. CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat Rev Mol Cell Biol 2011; 12:141-51; PMID:21346730; http://dx.doi.org/10.1038/nrm3072
   PubMed Web of Science ®Google Scholar
• Fritsche L, Weigert C, Haring HU, Lehmann R. How insulin receptor substrate proteins regulate the metabolic capacity of the liver–implications for health and disease. Curr Med Chem 2008; 15:1316-29; PMID:18537611
   PubMed Web of Science ®Google Scholar
• Cheng Z, Tseng Y, White MF. Insulin signaling meets mitochondria in metabolism. Trends Endocrinol Metab 2010; 21:589-98; PMID:20638297; http://dx.doi.org/10.1016/j.tem.2010.06.005
   PubMed Web of Science ®Google Scholar
• Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife 2015; 4:1-38; PMID:26267216; http://dx.doi.org/10.7554/eLife.05005.
   PubMed Web of Science ®Google Scholar
• Kozomara A, Griffiths-Jones S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 2014; 42:D68-73; PMID:24275495; http://dx.doi.org/10.1093/nar/gkt1181
   PubMed Web of Science ®Google Scholar
• REHMSMEIER M. Fast and effective prediction of microRNA/target duplexes. RNA 2004; 10:1507-17; PMID:15383676; http://dx.doi.org/10.1261/rna.5248604
   PubMed Web of Science ®Google Scholar
• Leone G, Degregori J, Yan Z, Jakoi L, Ishida S. E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes & Development 1998; 12:2120-30; PMID:9679057
   PubMed Web of Science ®Google Scholar
• McClellan KA, Ruzhynsky VA, Douda DN, Vanderluit JL, Ferguson KL, Chen D, Bremner R, Park DS, Leone G, Slack RS. Unique requirement for Rb/E2F3 in neuronal migration: evidence for cell cycle-independent functions. Mol Cell Biol 2007; 27:4825-43; PMID:17452454; http://dx.doi.org/10.1128/MCB.02100-06
   PubMed Web of Science ®Google Scholar
• Zhou X, Ji G, Ke X, Gu H, Jin W, Zhang G. MiR-141 Inhibits Gastric Cancer Proliferation by Interacting with Long Noncoding RNA MEG3 and Down-Regulating E2F3 Expression. Dig Dis Sci 2015; 60:3271-82; PMID:26233544; http://dx.doi.org/10.1007/s10620-015-3782-x
   PubMed Web of Science ®Google Scholar
• Peng C, Li N, Ng YK, Zhang J, Meier F, Theis FJ, Merkenschlager M, Chen W, Wurst W, Prakash N. A unilateral negative feedback loop between miR-200 microRNAs and Sox2/E2F3 controls neural progenitor cell-cycle exit and differentiation. J Neurosci 2012; 32:13292-308; PMID:22993445; http://dx.doi.org/10.1523/JNEUROSCI.2124-12.2012
   PubMed Web of Science ®Google Scholar
• Zhou J, Chen GB, Tang YC, Sinha RA, Wu Y, Yap CS, Wang G, Hu J, Xia X, Tan P. Genetic and bioinformatic analyses of the expression and function of PI3K regulatory subunit PIK3R3 in an Asian patient gastric cancer library. Bmc Medical Genomics 2012; 5:1-08; PMID:22876838; http://dx.doi.org/10.1186/1755-8794-5-34
   PubMed Web of Science ®Google Scholar
• Zhang L, Huang J, Yang N, Greshock J, Liang S, Hasegawa K, Giannakakis A, Poulos N, O'Brien-Jenkins A, Katsaros D, Butzow R, Weber BL et al. Coukos G. Integrative Genomic Analysis of Phosphatidylinositol 3′-Kinase Family Identifies PIK3R3 as a Potential Therapeutic Target in Epithelial Ovarian Cancer. Clinical Cancer Research 2007; 13:5314-21; PMID:17875760; http://dx.doi.org/10.1158/1078-0432.CCR-06-2660
   PubMed Web of Science ®Google Scholar
• Kim YW, Kim EY, Jeon D, Liu JL, Kim HS, Choi JW, Ahn WS. Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells. Drug Des Devel Ther 2014; 8:293-314; PMID:24591819; http://dx.doi.org/10.2147/DDDT.S51969
   PubMed Web of Science ®Google Scholar
• Chen L, Kong G, Zhang C, Dong H, Yang C. MicroRNA-432 functions as a tumor suppressor gene through targeting E2F3 and AXL in lung adenocarcinoma. Oncotarget 2016; 12:20041-53; PMID:26942465; http://dx.doi.org/10.18632/oncotarget.7884
   Web of Science ®Google Scholar
• Molkentin JD, Olson EN. Defining the regulatory networks for muscle development. Curr Opin Genet Dev 1996; 6:445-53; PMID:8791524; http://dx.doi.org/10.1016/S0959-437X(96)80066-9
   PubMed Web of Science ®Google Scholar
• Pownall ME, Gustafsson MK, Emerson CJ. Myogenic regulatory factors and the specification of muscle progenitors in vertebrate embryos. Annu Rev Cell Dev Biol 2002; 18:747-83; PMID:12142270; http://dx.doi.org/10.1146/annurev.Cellbio.18.012502.105758
   PubMed Web of Science ®Google Scholar
• Hibberd MG, Trentham DR. Relationships between chemical and mechanical events during muscular contraction. Annu Rev Biophys Biophys Chem 1986; 15:119-61; PMID:2941026; http://dx.doi.org/10.1146/annurev.bb.15.060186.001003
   PubMedGoogle Scholar
• McKinnell IW, Rudnicki MA. Molecular mechanisms of muscle atrophy. Cell 2004; 119:907-10; PMID:15620349; http://dx.doi.org/10.1016/j.cell.2004.12.007
   PubMed Web of Science ®Google Scholar
• Bassel-Duby R, Olson EN. Signaling pathways in skeletal muscle remodeling. Annu Rev Biochem 2006; 75:19-37; PMID:16756483; http://dx.doi.org/ 10.1146/annurev.biochem.75.103004.142622
   PubMed Web of Science ®Google Scholar
• Bai L, Liang R, Yang Y, Hou X, Wang Z, Zhu S, Wang C, Tang Z, Li K. MicroRNA-21 Regulates PI3K/Akt/mTOR Signaling by Targeting TGF betaI during Skeletal Muscle Development in Pigs. PLoS One 2015; 10:e119396; PMID:25950587; http://dx.doi.org/10.1371/journal.pone.0119396
   PubMed Web of Science ®Google Scholar
• Huang MB, Xu H, Xie SJ, Zhou H, Qu LH. Insulin-like growth factor-1 receptor is regulated by microRNA-133 during skeletal myogenesis. PLoS One 2011; 6:e29173; PMID:22195016; http://dx.doi.org/10.1371/journal.pone.0029173
   PubMed Web of Science ®Google Scholar